Dr Trevor Phillips joins Vectura
This article was originally published in Scrip
Executive Summary
Vectura Group, a company developing inhaled therapies for the treatment of respiratory diseases, has appointed Dr Trevor Phillips president of its US operations. Dr Phillips has held a number of senior roles in the pharmaceutical industry, including serving as CEO and president of Critical Therapeutics, following six years as the company's chief operating officer. He has also worked at Sepracor, Scotia Pharmaceuticals, Accenture, Glaxo Wellcome Research and Development and Simbec Research.